Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Risperdal OD Tab · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Risperdal OD / Risperdal Quicklet | EXPERIMENTAL | Risperdal OD (investigational drug) + Risperdal Quicklet (control drug) |
| Risperdal Quicklet / Risperdal OD | EXPERIMENTAL | Risperdal Quicklet (control drug) + Risperdal OD (investigational drug) |
| Name | Type | Description |
|---|---|---|
| Risperdal OD Tab. 2mg | DRUG | 1 tablet Risperdal OD 2 mg administered orally. |
| Risperdal Quicklet Tab. 2mg | DRUG | 1 tablet Risperdal Quicklet Tab. 2mg administered orally. |
Inclusion Criteria: * Healthy Korean participants weighing more than 50kg and within 20% normal lean body weight (standard weight) * Participant without congenital or chronic diseases and with no symptoms or findings as a result of internal examination * Participant who was deemed appropriate as a ...
Risperdal OD Tab is an orally disintegrating tablet formulation of risperidone being developed by Johnson & Johnson. In the clinical trial data available, it was studied in healthy volunteers to assess bioequivalence of the 2 mg dose. The drug is a small molecule therapeutic.
Risperdal OD Tab is developed by Johnson & Johnson, which trades under the ticker JNJ. The company conducted a bioequivalence study for the 2 mg formulation of Risperdal OD Tab in healthy volunteers.
Risperdal OD Tab is in Phase 1 clinical development. One Phase 1 trial has been completed, which evaluated the bioequivalence of the 2 mg dose in healthy volunteers. The drug is investigational and not yet approved.
Risperdal OD Tab has one completed clinical trial, NCT02012049, titled 'Bioequivalence Test for Risperdal 2mg of Janssen Korea.' This Phase 1 study enrolled 36 healthy volunteers aged 20 years and older, with no double-blind design and a controlled study type.
Risperdal OD Tab is an orally disintegrating tablet formulation of risperidone, an antipsychotic medication. The 'OD' in the name indicates the orally disintegrating dosage form, which dissolves in the mouth without water. The active ingredient is risperidone.